Cannabis Stocks Dive
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.
Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...
The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...
New York released updated cannabis industry data. The Congressional Cannabis Caucus has new leadership. Wisconsin’s governor calls for a ballot initiative on adult-use. The DEA faces charges of ...
Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...
A group of pro-cannabis entities scheduled to present in the forthcoming cannabis rescheduling hearing have filed a new ...
Recreational cannabis is now legal in 24 states and three more could legalize some form of marijuana sales this year. But ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback